ASSOCIATION OF AN IMMUNE-GENE SIGNATURE WITH PATHOLOGIC RESPONSE AND OUTCOME AFTER NEOADJUVANT PEMBROLIZUMAB (PEMBRO), COMPARED TO NEOADJUVANT CHEMOTHERAPY (NAC), IN MUSCLE-INVASIVE BLADDER CANCER (MIBC)

被引：0
|
作者：
Necchi, Andrea
Raggi, Daniele
Briganti, Alberto
Fare, Elena
Giannatempo, Patrizia
Marandino, Laura
Gallina, Andrea
Bianchi, Marco
Salonia, Andrea
Gandaglia, Giorgio
Fossati, Nicola
Capitanio, Umberto
Montorsi, Francesco
Boormans, Joost
Liu, Yang
de Jong, Joep
Dittamore, Ryan
Davicioni, Elai
Black, Peter
Gibb, Ewan
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP55-09
引用
收藏
页码：E841 / E841
页数：1
相关论文
共 50 条
  • [1] Association of an immune gene signature with pathologic response and outcome after neoadjuvant pembrolizumab (pembro), compared to neoadjuvant chemotherapy (NAC), in muscle-invasive bladder cancer (MIBC)
    Necchi, Andrea
    Raggi, Daniele
    Briganti, Alberto
    Fare, Elena
    Giannatempo, Patrizia
    Marandino, Laura
    Bianchi, Marco
    Gallina, Andrea
    Salonia, Andrea
    Gandaglia, Giorgio
    Fossati, Nicola
    Capitanio, Umberto
    Montorsi, Francesco
    Boormans, Joost L.
    Liu, Yang
    de Jong, Joep
    Black, Peter C.
    Dittamore, Ryan
    Davicioni, Elai
    Gibb, Ewan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [2] Impact of angiotensin inhibitors on pathologic complete response with neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC).
    Thomas, Jonathan
    Pond, Gregory Russell
    Curran, Catherine
    Freeman, Dory
    Ravi, Praful
    Mossanen, Matthew
    Preston, Mark A.
    Steele, Graeme S.
    Mantia, Charlene
    McGregor, Bradley Alexander
    Jain, Rakesh K.
    Sonpavde, Guru
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [3] BLADDER-SPARING SURGERY (BSS) FOR MUSCLE-INVASIVE BLADDER CANCER (MIBC) AFTER COMPLETE RESPONSE TO NEOADJUVANT CHEMOTHERAPY (NAC)
    Herr, Harry
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E1084 - E1084
  • [4] Assessment of sarcopenia as predictor of response and outcome after neoadjuvant chemotherapy (NAC) and radical cystectomy (RC) in muscle-invasive bladder cancer (MIBC).
    Grivas, Petros
    Zargar, Homi
    Ercole, Cesar Emilio
    Kovac, Evan
    Remer, Erick M.
    Karim, Wadih
    Emamekhoo, Hamid
    Stephenson, Andrew J.
    Fergany, Amr Farouk
    Gong, Michael C.
    Campbell, Steven C.
    Berglund, Ryan Kent
    Dreicer, Robert
    Rini, Brian I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer
    Bandini, Marco
    Ross, Jeffrey S.
    Raggi, Daniele
    Gallina, Andrea
    Colecchia, Maurizio
    Luciano, Roberta
    Giannatempo, Patrizia
    Fare, Elena
    Pederzoli, Filippo
    Bianchi, Marco
    Colombo, Renzo
    Gandaglia, Giorgio
    Fossati, Nicola
    Marandino, Laura
    Capitanio, Umberto
    Deho', Federico
    Ali, Siraj M.
    Madison, Russell
    Chung, Jon H.
    Salonia, Andrea
    Briganti, Alberto
    Montorsi, Francesco
    Necchi, Andrea
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (01) : 48 - 53
  • [6] Association of Medicaid expansion with racial disparities in timely neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer (MIBC).
    Jiang, Changchuan
    Perimbeti, Stuthi
    Deng, Lei
    Jatwani, Karan
    Roy, Arya
    Chatta, Gurkamal S.
    George, Saby
    Gopalakrishnan, Dharmesh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [7] Frequency and clinical implications of pathologic complete response (pCR) at cystectomy for muscle-invasive bladder cancer (MIBC) with or without neoadjuvant chemotherapy (NAC)
    Galsky, Matt D.
    Stensland, Kristian
    Sfakianos, John
    McBride, Russell Bailey
    Mehrazin, Reza
    Tsao, Che-Kai
    Boffetta, Paolo
    Oh, William K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [8] Impact of angiotensin-converting enzyme inhibitors (ACEi) on pathologic complete response with neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC).
    Thomas, Jonathan
    Skelton, William Paul
    Fallah, Parvaneh
    Jain, Rohit K.
    Ravi, Praful
    Mantia, Charlene
    McGregor, Bradley Alexander
    Nuzzo, Pier Vitale
    Adib, Elio
    El Zarif, Talal
    Curran, Catherine
    Preston, Mark A.
    Clinton, Timothy Nguyen
    Li, Roger
    Steele, Graeme S.
    Kassouf, Wassim
    Freeman, Dory
    Pond, Gregory Russell
    Jain, Rakesh K.
    Sonpavde, Guru P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [9] Immune correlates of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Ginwala, Rashida
    Macfarlane, Alexander
    Liu, David
    Alpaugh, R. K.
    Xiu, Joanne
    Gatalica, Zoran
    Korn, W. M.
    Van Allen, Eliezer M.
    Campbell, Kerry S.
    Kutikov, Alexander
    Plimack, Elizabeth
    Abbosh, Philip H.
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [10] Development of a biomarker-based nomogram to predict the pathologic response to neoadjuvant pembrolizumab in muscle-invasive urothelial bladder cancer (MIBC).
    Necchi, Andrea
    Bandini, Marco
    Raggi, Daniele
    Briganti, Alberto
    Fare, Elena
    Gallina, Andrea
    Colombo, Renzo
    Bianchi, Marco
    Colecchia, Maurizio
    Luciano, Roberta
    Salonia, Andrea
    Pederzoli, Filippo
    Ross, Jeffrey S.
    Madison, Russell
    Montorsi, Francesco
    Ali, Siraj M.
    Chung, Jon H.
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (15) : 28 - 29
12345